Market Closed -
Nyse
16:00:01 2024-04-26 EDT
|
5-day change
|
1st Jan Change
|
354.5
USD
|
-0.01%
|
|
+0.59%
|
+18.37%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
76,362
|
75,209
|
76,106
|
101,304
|
87,625
|
100,544
|
-
|
-
|
Enterprise Value (EV)
1 |
109,150
|
97,946
|
104,695
|
126,473
|
110,733
|
121,213
|
116,630
|
114,077
|
P/E ratio
|
15.2
x
|
9.07
x
|
14.6
x
|
15.6
x
|
17.2
x
|
15.2
x
|
13.5
x
|
12
x
|
Yield
|
0.02%
|
0.02%
|
1.74%
|
1.35%
|
1.64%
|
1.59%
|
1.7%
|
1.83%
|
Capitalization / Revenue
|
0.54
x
|
0.47
x
|
0.44
x
|
0.56
x
|
0.45
x
|
0.43
x
|
0.41
x
|
0.39
x
|
EV / Revenue
|
0.78
x
|
0.61
x
|
0.6
x
|
0.7
x
|
0.57
x
|
0.52
x
|
0.48
x
|
0.44
x
|
EV / EBITDA
|
10.2
x
|
8.85
x
|
9.42
x
|
11
x
|
9.24
x
|
8.93
x
|
8.09
x
|
7.31
x
|
EV / FCF
|
12.9
x
|
10.6
x
|
17.3
x
|
17.2
x
|
10.8
x
|
11
x
|
9.44
x
|
9.54
x
|
FCF Yield
|
7.73%
|
9.45%
|
5.77%
|
5.82%
|
9.25%
|
9.12%
|
10.6%
|
10.5%
|
Price to Book
|
1.68
x
|
1.47
x
|
1.57
x
|
2.21
x
|
1.89
x
|
2.17
x
|
2.02
x
|
1.67
x
|
Nbr of stocks (in thousands)
|
373,425
|
361,267
|
331,428
|
305,739
|
292,620
|
283,647
|
-
|
-
|
Reference price
2 |
204.5
|
208.2
|
229.6
|
331.3
|
299.4
|
354.5
|
354.5
|
354.5
|
Announcement Date
|
20-02-06
|
21-02-04
|
22-02-03
|
23-02-03
|
24-02-02
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
140,175
|
160,067
|
174,078
|
180,642
|
195,322
|
235,096
|
245,413
|
260,356
|
EBITDA
1 |
10,752
|
11,072
|
11,118
|
11,522
|
11,980
|
13,576
|
14,412
|
15,606
|
EBIT
1 |
8,887
|
8,153
|
7,935
|
8,414
|
8,536
|
9,898
|
10,764
|
11,449
|
Operating Margin
|
6.34%
|
5.09%
|
4.56%
|
4.66%
|
4.37%
|
4.21%
|
4.39%
|
4.4%
|
Earnings before Tax (EBT)
1 |
6,570
|
10,868
|
6,782
|
8,353
|
5,513
|
8,490
|
9,469
|
10,113
|
Net income
1 |
5,104
|
8,458
|
5,365
|
6,668
|
5,164
|
6,602
|
7,188
|
7,770
|
Net margin
|
3.64%
|
5.28%
|
3.08%
|
3.69%
|
2.64%
|
2.81%
|
2.93%
|
2.98%
|
EPS
2 |
13.44
|
22.96
|
15.73
|
21.30
|
17.39
|
23.29
|
26.31
|
29.47
|
Free Cash Flow
1 |
8,435
|
9,256
|
6,037
|
7,361
|
10,240
|
11,050
|
12,354
|
11,952
|
FCF margin
|
6.02%
|
5.78%
|
3.47%
|
4.07%
|
5.24%
|
4.7%
|
5.03%
|
4.59%
|
FCF Conversion (EBITDA)
|
78.45%
|
83.6%
|
54.3%
|
63.89%
|
85.48%
|
81.39%
|
85.72%
|
76.59%
|
FCF Conversion (Net income)
|
165.26%
|
109.43%
|
112.53%
|
110.39%
|
198.3%
|
167.36%
|
171.87%
|
153.83%
|
Dividend per Share
2 |
0.0400
|
0.0400
|
4.000
|
4.480
|
4.920
|
5.638
|
6.019
|
6.488
|
Announcement Date
|
20-02-06
|
21-02-04
|
22-02-03
|
23-02-03
|
24-02-02
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
44,310
|
45,676
|
44,005
|
45,480
|
45,280
|
45,743
|
46,479
|
48,616
|
49,048
|
51,149
|
56,627
|
58,503
|
58,915
|
61,037
|
58,855
|
EBITDA
1 |
3,028
|
2,530
|
3,022
|
3,140
|
2,867
|
2,445
|
2,684
|
2,976
|
3,220
|
3,133
|
3,056
|
3,286
|
3,502
|
3,510
|
3,146
|
EBIT
1 |
2,362
|
1,537
|
2,167
|
2,381
|
2,141
|
1,725
|
2,015
|
2,221
|
2,454
|
2,060
|
2,196
|
2,436
|
2,629
|
2,622
|
2,432
|
Operating Margin
|
5.33%
|
3.37%
|
4.92%
|
5.24%
|
4.73%
|
3.77%
|
4.34%
|
4.57%
|
5%
|
4.03%
|
3.88%
|
4.16%
|
4.46%
|
4.3%
|
4.13%
|
Earnings before Tax (EBT)
1 |
2,059
|
1,312
|
1,549
|
1,985
|
3,491
|
1,328
|
1,601
|
1,884
|
1,840
|
188
|
1,834
|
2,067
|
2,275
|
2,266
|
2,083
|
Net income
1 |
1,621
|
1,116
|
1,183
|
1,559
|
2,757
|
1,169
|
1,267
|
1,460
|
1,408
|
1,029
|
1,417
|
1,603
|
1,779
|
1,774
|
1,558
|
Net margin
|
3.66%
|
2.44%
|
2.69%
|
3.43%
|
6.09%
|
2.56%
|
2.73%
|
3%
|
2.87%
|
2.01%
|
2.5%
|
2.74%
|
3.02%
|
2.91%
|
2.65%
|
EPS
2 |
4.800
|
3.390
|
3.680
|
4.900
|
8.970
|
3.830
|
4.240
|
4.920
|
4.740
|
3.490
|
4.894
|
5.654
|
6.349
|
6.314
|
5.561
|
Dividend per Share
2 |
1.000
|
1.000
|
1.120
|
1.120
|
1.120
|
1.120
|
1.230
|
1.230
|
1.230
|
1.230
|
1.375
|
1.375
|
1.375
|
1.375
|
1.440
|
Announcement Date
|
21-11-04
|
22-02-03
|
22-05-06
|
22-08-04
|
22-11-03
|
23-02-03
|
23-05-05
|
23-08-03
|
23-11-02
|
24-02-02
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
32,788
|
22,737
|
28,589
|
25,169
|
23,108
|
20,668
|
16,086
|
13,532
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.049
x
|
2.054
x
|
2.571
x
|
2.184
x
|
1.929
x
|
1.522
x
|
1.116
x
|
0.8671
x
|
Free Cash Flow
1 |
8,435
|
9,256
|
6,037
|
7,361
|
10,240
|
11,050
|
12,354
|
11,952
|
ROE (net income / shareholders' equity)
|
15%
|
14.2%
|
14.3%
|
15.8%
|
16.4%
|
17.5%
|
19%
|
17.8%
|
ROA (Net income/ Total Assets)
|
3.33%
|
5.44%
|
4.5%
|
4.88%
|
5.02%
|
4.71%
|
4.96%
|
4.86%
|
Assets
1 |
153,227
|
155,612
|
119,267
|
136,779
|
102,838
|
140,206
|
145,017
|
159,920
|
Book Value Per Share
2 |
122.0
|
142.0
|
146.0
|
150.0
|
158.0
|
164.0
|
176.0
|
213.0
|
Cash Flow per Share
2 |
25.00
|
28.10
|
21.10
|
27.60
|
39.80
|
34.40
|
41.70
|
-
|
Capex
1 |
1,050
|
1,094
|
1,154
|
1,295
|
1,573
|
1,555
|
1,629
|
1,747
|
Capex / Sales
|
0.75%
|
0.68%
|
0.66%
|
0.72%
|
0.81%
|
0.66%
|
0.66%
|
0.67%
|
Announcement Date
|
20-02-06
|
21-02-04
|
22-02-03
|
23-02-03
|
24-02-02
|
-
|
-
|
-
|
Last Close Price
354.5
USD Average target price
381.4
USD Spread / Average Target +7.61% Consensus |
1st Jan change
|
Capi.
|
---|
| +18.37% | 101B | | +13.93% | 125B | | -0.28% | 39.69B | | -33.18% | 36.86B | | -5.28% | 20.05B | | -13.82% | 3.08B | | -39.49% | 993M | | -28.58% | 337M |
Other Managed Healthcare
|